Name Symbol Market Type
Novartis AG NYSE:NVS NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  +0.00 +0.00% 86.70 - - - 0 11:00:21

Correction to Novartis Eye-Disease Drug Article on Tuesday

09/10/2019 6:38pm

Dow Jones News


Novartis (NYSE:NVS)
Historical Stock Chart

1 Month : From Sep 2019 to Oct 2019

Click Here for more Novartis Charts.

Beovu showed it was non-inferior in terms of improvements in visual acuity for patients compared with rival treatment aflibercept. "Novartis Sees Blockbuster Potential in Eye-Disease Drug -- Update," on Oct. 8 at GMT 1216, misstated that Beovu achieved superior visual improvements compared with aflibercept in the fifth paragraph. The error also appeared in an earlier version of the story, "Novartis: US FDA Approves Eye-Disease Treatment Beovu," at 0535 GMT the same day.

 

(END) Dow Jones Newswires

October 09, 2019 13:23 ET (17:23 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

1 Year Novartis Chart

1 Year Novartis Chart

1 Month Novartis Chart

1 Month Novartis Chart
Your Recent History
NYSE
NVS
Novartis
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191016 10:15:22